Published in TB and Outbreaks Week, May 26th, 2009
"The existing vaccine, BCG, confers only variable protection against pulomonary disease. Exposure to environmental mycobacteria may contribute to this variability in protective efficacy. Protective immunity against Mycobacterium tuberculosis is dependant on a cell-mediated immune response. Boosting BCG with a subunit vaccine, and/or replacing BCG with an improved BCG...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week